Therapy Areas: AIDS & HIV
Replicate Bioscience awarded Gates Foundation grant to advance srRNA vaccine candidates for TB
22 June 2026 - Replicate Bioscience, a clinical-stage company developing novel self-replicating RNA (srRNA) technology for applications across infectious disease, immunology, and other therapeutic are...
Breckenridge Pharmaceutical launches Pomalidomide Capsules in US market
3 March 2026 - Breckenridge Pharmaceutical Inc, the US subsidiary of Spain-based Towa International, announced on Monday the launch of Pomalidomide Capsules, a generic version of Pomalyst by Celgene (...
Bionpharma and STEERLife's Etravirine tablets approved by US FDA
14 January 2026 - STEERLife, the life sciences division of India-based STEER World, and Bionpharma Inc, a US-based pharmaceutical company, announced on Tuesday that Bionpharma has received Abbreviated...
Workit Health Reopens Services in California, Expanding Statewide Access to Virtual Opioid and Alcohol Treatment
28 November 2025 - * Evidence-based digital care and medication-assisted treatment now offered across the state through a mobile app.Workit Health, recognised as one of the United States' most tr...
Merck reports positive Phase 3 data for investigational two-drug HIV regimen doravirine/islatravir
15 October 2025 - Biopharmaceutical company Merck (NYSE: MRK), known as MSD outside the US and Canada, reported on Wednesday that it has presented new data from two Phase 3 studies evaluating its inve...
AusperBio completes patient enrolment in two Phase II clinical trials of AHB-137
19 September 2025 - AusperBio Therapeutics, Inc. and Ausper Biopharma Co., Ltd. (collectively AusperBio), a clinical-stage biotechnology company, announced on Thursday that it has completed patient en...